FIELD: organic chemistry.
SUBSTANCE: invention relates to a process for the preparation of a compound of formula (Ia), wherein the said process comprises (a) reacting a compound of formula (VII), where R7 is selected from the group consisting of hydrogen, C1-C8-alkyl, C2-C8- alkenyl, C2-C8-alkynyl, C3-C8-cycloalkyl, C3-C8-cycloalkenyl, 3-8-membered heterocyclic fragment, aryl and heteroaryl; and X is chloro; with a compound of formula (VII-X), where PG is hydrogen; to form a compound of formula (VIII-d); (b) reacting a compound of formula (VIII) with morpholine to form a compound of formula (Xd); c) reaction of a compound of formula (IV) with 1.1'-carbonyldiimidazole or nitrophenylchloroformate to give a compound of formula (III) wherein R5 is 1-imidazolyl or nitrophenyl-O-; d) isolation and purification of the compound of formula (III); (e) reacting a compound of formula (III) with a compound of formula (Xd), said reaction being carried out at a temperature of from about 10 to 50°C for 6 to 48 hours and at a concentration of the compound of formula (III) from about 1 M to 3 M and a molar ratio of compound of formula (III) and compound of formula (Xd) 1:1, to obtain a compound of formula (Va), and (f) reacting a compound of formula (Va) with a cyclization reagent to form a compound of formula (I-a).
EFFECT: method for obtaining biologically active molecules, respiratory syncytial virus (RSV) inhibitors.
14 cl, 4 ex
, , , ,
,
Title | Year | Author | Number |
---|---|---|---|
CYCLOSPORIN ANALOGUES FOR PREVENTION OR TREATMENT OF HEPATITE C INFECTION | 2010 |
|
RU2492181C2 |
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2015 |
|
RU2707280C2 |
QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | 2008 |
|
RU2493160C2 |
METHOD FOR PREPARING SULFONYLCARBAMATE BILE ACID DERIVATIVES | 2018 |
|
RU2791682C2 |
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2016 |
|
RU2712099C2 |
HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2544010C2 |
COMBINATION THERAPY USING DIARYL MACROCYCLIC COMPOUNDS | 2018 |
|
RU2784853C2 |
TETRAZOLE-CONTAINING INHIBITORS OF APOPTOTIC SIGNAL-REGULATING KINASE 1 AND METHODS OF THEIR USE | 2019 |
|
RU2807545C2 |
QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS | 2007 |
|
RU2475494C2 |
CHIRAL DIARYL MACROCYCLES AND USE THEREOF | 2016 |
|
RU2728579C2 |
Authors
Dates
2023-04-11—Published
2018-02-16—Filed